Rigel Pharmaceuticals, Inc. (RIGL)
NASDAQ: RIGL · Real-Time Price · USD
30.56
+0.05 (0.16%)
At close: Apr 28, 2026, 4:00 PM EDT
30.56
0.00 (0.00%)
Pre-market: Apr 29, 2026, 4:00 AM EDT
Rigel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 565 | 777 | 296 | 253 | 259 | 453 | |
| Market Cap Growth | 94.41% | 162.39% | 17.18% | -2.48% | -42.79% | -23.38% | |
| Enterprise Value | 463 | 701 | 335 | 295 | 269 | 403 | |
| Last Close Price | 30.56 | 42.83 | 16.82 | 14.50 | 15.00 | 26.50 | |
| PE Ratio | 1.57 | 2.12 | 16.95 | - | - | - | |
| Forward PE | 7.60 | 10.49 | 17.39 | - | - | - | |
| PS Ratio | 1.92 | 2.64 | 1.65 | 2.16 | 2.24 | 3.27 | |
| PB Ratio | 1.43 | 1.99 | 90.11 | -8.83 | -19.04 | 14.92 | |
| P/TBV Ratio | 1.54 | 2.12 | - | - | - | 14.92 | |
| P/FCF Ratio | 7.46 | 10.28 | 9.43 | - | - | 86.30 | |
| P/OCF Ratio | 7.46 | 10.28 | 9.41 | - | - | 77.10 | |
| EV/Sales Ratio | 1.57 | 2.38 | 1.87 | 2.52 | 2.33 | 2.90 | |
| EV/EBITDA Ratio | 3.62 | 5.48 | 12.69 | - | - | - | |
| EV/EBIT Ratio | 3.69 | 5.59 | 13.86 | - | - | - | |
| EV/FCF Ratio | 6.12 | 9.27 | 10.67 | - | - | 76.67 | |
| Debt / Equity Ratio | 0.14 | 0.14 | 30.40 | -3.64 | -6.44 | 3.01 | |
| Debt / EBITDA Ratio | 0.41 | 0.41 | 3.68 | - | - | - | |
| Debt / FCF Ratio | 0.71 | 0.71 | 3.18 | - | - | 17.38 | |
| Net Debt / Equity Ratio | -0.26 | -0.26 | 6.88 | -1.65 | -2.17 | -1.11 | |
| Net Debt / EBITDA Ratio | -0.79 | -0.79 | 0.86 | -2.45 | -0.51 | 1.84 | |
| Net Debt / FCF Ratio | -1.34 | -1.34 | 0.72 | -8.22 | -0.40 | -6.42 | |
| Asset Turnover | 0.87 | 0.87 | 1.27 | 0.93 | 0.77 | 1.00 | |
| Inventory Turnover | 3.20 | 3.20 | 5.50 | 2.76 | 5.17 | 10.82 | |
| Quick Ratio | 2.08 | 2.08 | 1.88 | 1.64 | 1.51 | 2.21 | |
| Current Ratio | 2.42 | 2.42 | 2.13 | 1.86 | 1.78 | 2.43 | |
| Return on Equity (ROE) | 185.94% | 185.94% | - | - | -699.04% | -55.63% | |
| Return on Assets (ROA) | 23.15% | 23.15% | 10.75% | -10.18% | -24.34% | -8.77% | |
| Return on Invested Capital (ROIC) | 75.77% | 79.47% | 103.51% | -118.72% | -932.00% | -312.65% | |
| Return on Capital Employed (ROCE) | 30.30% | 30.30% | 24.00% | -32.00% | -85.00% | -18.80% | |
| Earnings Yield | 64.99% | 47.21% | 5.90% | -9.92% | -22.59% | -3.95% | |
| FCF Yield | 13.40% | 9.73% | 10.61% | -2.27% | -28.62% | 1.16% | |
| Buyback Yield / Dilution | -6.52% | -6.52% | -1.64% | -2.07% | 0.00% | -1.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.